Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>
In several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40% of patients with HCV genotype 1 and up to 20% of patients with genotype 2 or 3. Several approaches are now underway to prevent or ameliorate mechanisms of disease progression. In Asia, and particularly in Japan, Glycyrrhizine-SNMC has been widely used for this purpose. At present, SNMC is under clinical evaluation in Europe.
| Serija: | Falk Symposium |
| Leidėjas: | Springer Netherlands |
| Išleidimo metai: | 2004 |
| Knygos puslapių skaičius: | 140 |
| ISBN-10: | 0792387961 |
| ISBN-13: | 9780792387961 |
| Formatas: | 241 x 160 x 13 mm. Knyga kietu viršeliu |
| Kalba: | Anglų |
Parašykite atsiliepimą apie „Prevention of Progression in Chronic Liver Disease: An Update on SNMC (Stronger Neo-Minophagen C). In honour of Hans Poppers 100th birthday“
